Liver Fibrosis
The Liver Fibrosis SIG is an interactive group of investigators focusing on the pathogenesis, diagnosis, and development of therapeutics for liver fibrosis and outcomes. This SIG aims to broaden our knowledge of the disease and foster collaborations in basic and translational/clinical studies of liver fibrosis. The Liver Fibrosis SIG sponsors Programs at the AASLD Annual Meeting, identifies emerging topics in fibrosis research, and develops educational webinar programs.
SIG Leadership
- Chair
- Robert F. Schwabe, MD
- Vice Chair
- Heather L. Francis, PhD, FAASLD
- Staff Liaisons
- Akuender Dot
- Patricia Marshall
- Associate Lead
- Lindsey Kennedy, PhD
- Trainee Lead
- Vik Meadows, PhD
- Steering Committees
- Gianfranco Alpini, PhD, FAASLD
- Leila Gobejishvili, PhD
- Tatiana Kisseleva, MD, PhD
- Wajahat Z. Mehal, MD, FAASLD
- Natalia Nieto, PhD